Establishment and Genetic Profiling of Platinum/Taxane Doublet-Resistant Cells Generated by Hybridizing Single Resistant Cells
Background: Current standard chemotherapy for gynecologic malignancies consists of platinum agent and taxane though, many patients experience the relapse of disease with drug resistance making the following therapy unsuccessful. It’s a compelling question whether the mechanisms of doubly resistance...
Saved in:
| Main Authors: | Seiji Isonishi, Rika Saito, Noriko Yamaguchi, Saburo Saito |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
IMR Press
2022-09-01
|
| Series: | Clinical and Experimental Obstetrics & Gynecology |
| Subjects: | |
| Online Access: | https://www.imrpress.com/journal/CEOG/49/10/10.31083/j.ceog4910229 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
TAXANES IN THE TREATMENT OF CASTRATION-RESISTANT PROSTATE CANCER
by: T. N. Skvortsova, et al.
Published: (2017-01-01) -
Efficacy and safety of taxane plus ramucirumab for advanced gastric cancer after chemotherapy plus nivolumab
by: Toshihiko Matsumoto, et al.
Published: (2025-08-01) -
Second-line Chemotherapy for Advanced Bladder Cancer: Taxanes Versus Vinflunine
by: Bilgin Demir, et al.
Published: (2025-08-01) -
Child outcomes after prenatal exposure to platinum and taxane-based chemotherapy: an unplanned interim analysis of the international network on cancer, infertility, and pregnancy studyResearch in context
by: Indra A. Van Assche, et al.
Published: (2024-12-01) -
MicroRNA-dependent mechanisms of taxane resistance in breast cancer
by: V. S. Apollonova, et al.
Published: (2022-12-01)